Asia-Pacific consensus for the management of osteoporosis in men
- PMID: 40464984
- PMCID: PMC12209010
- DOI: 10.1007/s00198-025-07559-1
Asia-Pacific consensus for the management of osteoporosis in men
Abstract
Osteoporosis in men is an underdiagnosed and undertreated condition that leads to significant morbidity and mortality, particularly in the aging population. This consensus report provides tailored guidelines for diagnosing, preventing, and treating male osteoporosis in the Asia-Pacific region by integrating global best practices with regional adaptations.
Purpose: To establish evidence-based, region-specific guidelines for the management of male osteoporosis in the Asia-Pacific region, addressing demographic and lifestyle factors.
Methods: Expert feedback was gathered through premeeting reviews, consensus conferences, and collaborative discussions. A life-course approach was employed to align international best practices with Asia-Pacific-specific needs, emphasizing continuous monitoring and intervention from middle age onward.
Results: The 12 consensus strategies systematically approach male osteoporosis management, addressing screening, diagnosis, treatment, and long-term follow-up. Recommendations include the assessment of fracture risk for men aged 50 years and above, use of dual-energy X-ray absorptiometry (DXA) testing for men aged 70 years and above, lifestyle modifications, and pharmacological interventions such as bisphosphonates, denosumab, and anabolic agents for high-risk patients. Secondary causes of osteoporosis were highlighted, along with the establishment of fracture liaison services (FLSs) to improve long-term care. A life-course approach was proposed to optimize bone health throughout men's lives.
Conclusion: This consensus provides a comprehensive framework tailored to the Asia-Pacific region for diagnosing, preventing, and managing osteoporosis in men. By addressing region-specific challenges and promoting evidence-based interventions, the latest guidelines incorporating the consensus may depict the conceptual direction in reducing fracture risk and improving long-term bone health outcomes for osteoporosis in men.
Keywords: Asia–Pacific region; Men; consensus; fractures; osteoporosis.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Conflicts of interest: None.
Similar articles
-
Osteoporosis: A Review.JAMA. 2025 Sep 9;334(10):894-907. doi: 10.1001/jama.2025.6003. JAMA. 2025. PMID: 40587168 Review.
-
Hail Lifestyle Medicine consensus position statement as a medical specialty: Middle Eastern perspective.Front Public Health. 2025 Jun 20;13:1455871. doi: 10.3389/fpubh.2025.1455871. eCollection 2025. Front Public Health. 2025. PMID: 40620567 Free PMC article.
-
The National Osteoporosis Foundation's position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations.Osteoporos Int. 2016 Apr;27(4):1281-1386. doi: 10.1007/s00198-015-3440-3. Epub 2016 Feb 8. Osteoporos Int. 2016. PMID: 26856587 Free PMC article.
-
A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis.Health Technol Assess. 2005 Jun;9(22):1-160. doi: 10.3310/hta9220. Health Technol Assess. 2005. PMID: 15929857
-
Screening to Prevent Osteoporotic Fractures: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.JAMA. 2018 Jun 26;319(24):2532-2551. doi: 10.1001/jama.2018.6537. JAMA. 2018. PMID: 29946734
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical